OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm.

MLA

Pedraza, María Isabel, et al. “OnabotulinumtoxinA Treatment for Chronic Migraine: Experience in 52 Patients Treated with the PREEMPT Paradigm.” SpringerPlus, vol. 4, Apr. 2015, p. 176. EBSCOhost, https://doi.org/10.1186/s40064-015-0957-z.

APA

Pedraza, M. I., de la Cruz, C., Ruiz, M., López-Mesonero, L., Martínez, E., de Lera, M., & Guerrero, Á. L. (2015). OnabotulinumtoxinA treatment for chronic migraine: experience in 52 patients treated with the PREEMPT paradigm. SpringerPlus, 4, 176. https://doi.org/10.1186/s40064-015-0957-z

Chicago

Pedraza, María Isabel, Carolina de la Cruz, Marina Ruiz, Luis López-Mesonero, Elena Martínez, Mercedes de Lera, and Ángel Luis Guerrero. 2015. “OnabotulinumtoxinA Treatment for Chronic Migraine: Experience in 52 Patients Treated with the PREEMPT Paradigm.” SpringerPlus 4 (April): 176. doi:10.1186/s40064-015-0957-z.